News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,499 Results
Type
Article (88833)
Company Profile (816)
Press Release (794828)
Multimedia
Podcasts (240)
Webinars (35)
Section
Business (233615)
Career Advice (4163)
Deals (40000)
Drug Delivery (179)
Drug Development (91735)
Employer Resources (207)
FDA (18564)
Job Trends (17490)
News (398786)
Policy (40016)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (238)
Alzheimer's disease (1982)
Antibody-drug conjugate (ADC) (561)
Approvals (18919)
Artificial intelligence (890)
ASCO (345)
Autoimmune disease (365)
Automation (66)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (480)
Bladder cancer (212)
Brain cancer (85)
Breast cancer (841)
Cancer (6647)
Cardiovascular disease (560)
Career advice (3599)
Career pathing (52)
CAR-T (388)
CDC (76)
Celiac Disease (3)
Cell therapy (1083)
Cervical cancer (56)
Clinical research (79148)
Collaboration (2401)
Commercialization (1)
Company closure (8)
Compensation (1537)
Complete response letters (106)
COVID-19 (3043)
CRISPR (126)
C-suite (1307)
Cystic fibrosis (168)
Data (8807)
Decentralized trials (3)
Denatured (92)
Depression (199)
Dermatology (97)
Diabetes (714)
Diagnostics (7613)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (442)
Drug pricing (247)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102506)
Editorial (80)
Employer branding (25)
Employer resources (174)
Events (138803)
Executive appointments (1202)
FDA (22688)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1975)
Gene editing (274)
Generative AI (91)
Gene therapy (858)
GLP-1 (1288)
Government (5563)
Grass and pollen (8)
Guidances (421)
Healthcare (21267)
Hematology (198)
HIV (98)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (214)
Infectious disease (3450)
Inflammatory bowel disease (244)
Inflation Reduction Act (17)
Influenza (153)
Intellectual property (326)
Interviews (822)
IPO (18006)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (123)
Layoffs (690)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (878)
Lymphoma (481)
Machine learning (68)
Management (66)
Manufacturing (1251)
Marketing (1)
MASH (228)
Medical affairs (1)
Medical device (15287)
Medtech (15457)
Mergers & acquisitions (23311)
Metabolic disorders (1843)
mRNA (273)
Multiple sclerosis (207)
NASH (24)
Neurodegenerative disease (518)
Neuropsychiatric disorders (130)
Neuroscience (3759)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (82)
Obesity (876)
Opinion (375)
Ovarian cancer (246)
Pain (286)
Pancreatic cancer (363)
Parkinson's disease (422)
Partnered (41)
Patents (664)
Patient recruitment (774)
Peanut (71)
People (68057)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24461)
Phase 2 (34387)
Phase 3 (25848)
Pipeline (9944)
Policy (401)
Postmarket research (3560)
Preclinical (10994)
Press Release (72)
Prostate cancer (352)
Psychedelics (73)
Radiopharmaceuticals (374)
Rare diseases (1283)
Real estate (7462)
Recruiting (81)
Regulatory (30469)
Reports (77)
Research institute (2772)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (338)
Series B (243)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1317)
Venture capital (137)
Weight loss (600)
Women's health (144)
Worklife (24)
Date
Today (74)
Last 7 days (462)
Last 30 days (2695)
Last 365 days (33249)
2026 (16862)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (406)
Arkansas (16)
Asia (52352)
Australia (9198)
California (14488)
Canada (4047)
China (1600)
Colorado (623)
Connecticut (644)
Delaware (450)
Europe (120715)
Florida (2162)
Georgia (470)
Hawaii (4)
Idaho (70)
Illinois (1265)
India (105)
Indiana (668)
Iowa (26)
Japan (609)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1753)
Massachusetts (10614)
Michigan (427)
Minnesota (807)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3843)
New Mexico (35)
New York (3813)
North Carolina (1948)
North Dakota (11)
Northern California (7205)
Ohio (454)
Oklahoma (27)
Oregon (55)
Pennsylvania (2848)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (89)
South Dakota (2)
Southern California (5690)
Tennessee (232)
Texas (2366)
United States (51864)
Utah (432)
Vermont (2)
Virginia (373)
Washington D.C. (89)
Washington State (1190)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,499 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
China’s Haisco Pharmaceutical continues to wield deals, this time out-licensing rights to two late-stage programs to New Jersey biotech Nuvectis.
June 22, 2026
·
2 min read
·
Gabrielle Masson
Policy
HHS debuts ‘unprecedented’ initiative to ‘restore American leadership’ in clinical trials
Among the health department’s efforts is an expedited investigational new drug pilot program that would leverage collaborations with U.S. research institutions to reduce early trial timelines by as much as 12 months.
June 22, 2026
·
3 min read
·
Heather McKenzie
Press Releases
BIO 2026 – Cytomos showcases groundbreaking new digital platform AuraCyt®, which enables earlier, smarter bioprocessing decisions
At this year’s annual meeting of the Bio International Convention (BIO) in San Diego, CA, TechBio company Cytomos (www.cytomos.com) is showcasing their flagship cell analytic intelligence platform AuraCyt® – together with its novel benchtop technology Celledonia® – which is set to revolutionise predictive cell analytics.
June 22, 2026
·
1 min read
Press Releases
Yellowbird Diagnostics Completes Dosing in First-in-Human Phase 1 Trial of NeuCaVis(TM)
Human data demonstrates translation of key findings from preclinical studies
June 22, 2026
·
2 min read
FDA
REGENXBIO to resubmit application for Hunter gene therapy after FDA’s most recent pivot
The resubmission for RGX-121, expected in the third quarter, comes as the FDA has deemed REGENXBIO’s existing data “sufficient” to support an accelerated filing. It immediately follows a similar reversal of position regarding uniQure’s embattled Huntington’s disease gene therapy.
June 22, 2026
·
3 min read
·
Heather McKenzie
Psychedelics
Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial
Results for Definium Therapeutics psychedelic candidate for major depressive disorder “exceeded expectations,” according to Stifel, while Jefferies called the efficacy data “profound.”
June 22, 2026
·
2 min read
·
Michael Gibney
Funding
Sofinnova, Sanofi alum unveil Bionyra with $165M and next-gen immunology assets
Formed by Sofinnova Partners and former Sanofi executive Frédéric Marrache, Bionyra Pharma emerged from stealth Monday with an initial focus in inflammatory bowel disease and atopic dermatitis.
June 22, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
June 22, 2026
·
6 min read
Press Releases
Catheter Precision, Inc. Announces Allowance of Key Intellectual Property
June 22, 2026
·
3 min read
Press Releases
Prolium Bioscience Announces First Patient Dosed in its Multinational, Phase 1/2 Study of PRO-203 in Systemic Sclerosis, and Last Patient, Last Visit in an Investigator-Led Study of PRO-203 in Refractory Lupus Nephritis
June 22, 2026
·
3 min read
1 of 88,450
Next
